Back to the overview
Agent passport

Apollo Hospitals AILF

Apollo Hospitals Enterprise Ltd · Operations & Productivity

SaaSNo attestation published

Certification per Microsoft Marketplace.

Liver fibrosisMultivariable Liver Fibrosis Staging Prediction Using Machine Learning in NAFLD patients
Provenance reach4 of 12 layers traced

Evidence tier Source Confirmed · 8 captures on record

User ratingNot rated0 reviews on the listing
Runs onSaaSSaaS
ProvenanceUnknown44% of the provenance layers this product can disclose
Evidence riskHighSign in to see the basis for this band.

What the publisher says

As described on Microsoft Marketplace.

  • A machine learning model

developed using Indian data demonstrates higher accuracy compared to

Show the rest of the publisher’s description (23 more lines)

conventional risk scores.

  • Feedback Loop from the

prospective use in patients

  • Comprehensive & Holistic

Risk Assessment

  • Validated at different

National Institutions

  • Integrated Clinical Decision

Support Tool (What Next to Do)

  • QMS: ISO

13485:2016 Certified, MDSAP Certified

Interpretation & Adoption Message

  • AI Algorithm + Clinicians: This risk

assessment tool has been built as an adjunct tool for physicians to

identify global/holistic risk for Liver Fibrosis in NAFLD patients.

  • Risk Identification and

Prevention: This Risk Assessment Tool should not be used to diagnose Liver

Fibrosis. Its limitations include already-diagnosed Liver fibrosis and

currently under treatment.

  • Where to use: This risk assessment

tool has been prepared for use in Preventive Gastroenterology and Liver Disease Screening programs at Outpatient Clinics, Emergency Rooms, and

Health Check Clinics, specifically those focusing on Non-Alcoholic Fatty

Liver Disease.

Preview

4 images
Apollo Hospitals AILF preview 1Apollo Hospitals AILF preview 2Apollo Hospitals AILF preview 3Apollo Hospitals AILF preview 4

Agent build and provenance

Sign in to see the provenance.

The evidence, the layer-by-layer tracing, the risk basis, and the cross-marketplace links are open to signed-in accounts.

Sign in

Compliance

Government
  • FedRAMPConfirmedNot listed90%, registry-checkedNo FedRAMP Marketplace entry matched this vendor's domain, checked 2026-08-27registry recordas observed 2026-08-27

Confirmed means matched to a public authoritative registry. Claimed means the vendor or its listing states it, not yet cross-checked. A framework not shown was not found in any source we hold, which is not evidence against it. Not listed means a scoped registry check found no match for this vendor's domain: a No is a scoped registry check, not a compliance judgment. Confidence bands: 95% domain-verified, 90% registry-checked, 80% self-attested, 70% weak signal. Self-attested items marked “vendor's site” are gathered from the vendor's own website and are not verified by us.

Vendor

External enrichment · as of 2026-08-07

CompanyApollo Hospitals Enterprise LimitedAutomated
HQIndiaAutomated
IndustryHealth CareAutomated
Websitehttps://www.apollohospitals.com/

Plans and pricing as listed

1 listed
AILF Subscription Plan
  • API Call Details/Unit Price: $3.65 per api call
$31,390.00/month
AILF Subscription Plan

Sources

Marketplace listingmarketplace.microsoft.comSource
Privacy PolicyPrivacy PolicySource

Publisher resources

3 links
Apollo AILF walkthrough videowww.youtube.comSource
Pricing
Paid
1 plan listed
Delivery
SaaS
https://clinical-ai-apps.apollohospitals.com/
Open the source listing ↗

Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.